Victory Capital Management Inc Immunocore Holdings PLC Transaction History

Victory Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	BUY	$46.12 - $65.71 $7.83 Million - $11.2 Million	169,851 New	169,851 $8.4 Million
Q4 2021 Feb 07, 2022	SELL	$27.58 - $40.0 $37,012 - $53,680	-1,342 Reduced 14.08%	8,186 $280,000
Q2 2021 Aug 03, 2021	SELL	$32.22 - $41.5 $15,207 - $19,588	-472 Reduced 4.72%	9,528 $372,000
Q1 2021 May 04, 2021	BUY	$36.3 - $56.34 $363,000 - $563,400	10,000 New	10,000 $426,000

141

41.4M

197K

451K

Ticker IMCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,897,100
Market Cap $1.24B
Description
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.